Gallant Therapeutics announces study for feline stem cell therapyDecember 18, 2023Gallant Therapeutics, an animal health biotechnology company announced the launch of a study to evaluate the safety and efficacy of its novel allogeneic stem cell therapy candidate to support FDA conditional approval in cats with refractory feline chronic gingivostomatitis (FCGS), the JEDI study.
SPONSORED CONTENTIs your parasite protocol missing something?Adding Hill's GI nutrition to your parasite protocol supports GI healing for more complete diarrhea management than medication alone. + Learn More
Brain Teaser: Can you solve this puzzle?December 7, 2023Presentation: A six-year-old female spayed domestic shorthair cat presents for three years of constipation.
Creating feline-friendly housingNovember 21, 2023Focusing on essential cat needs can create a containment area that positively affects the patient's well-being and improves your ability to assess and treat them effectively, which can lead to better outcomes.
Brain Teaser: Can you solve this puzzle?November 13, 2023Presentation: A 12-week-old kitten presents for palpable defect in sternum.
FDA-approved feline diabetes oral liquid med distributes in the U.S.October 24, 2023Senvelgo, Boehringer Ingelheim’s oral solution for diabetic cats, eliminates the need for twice-daily needle injection and complex monitoring
Generic feline allergic dermatitis med OKed by FDAApril 10, 2023Cats who find themselves constantly licking, chewing, and scratching their skin due to feline allergic dermatitis can now benefit from a newly approved medication.
Deadly feline cancer may soon have new treatment optionsMarch 10, 2023Cats afflicted with a deadly type of cancer may soon have renewed hope, thanks to a promising new treatment being researched in Canada.
Nutritional support for pets with cancerJanuary 31, 2023Cancer is common in pets and may result in metabolic changes that can lead to malnutrition. As cancer progresses, signs include decreased appetite, lethargy and weight loss, and, in advanced stages, a loss of body fat and lean muscle mass.
Feline intestinal lymphoma, cognitive dysfunction to be exploredDecember 22, 2022Tooth resorption, cognitive dysfunction syndrome, and oral squamous cell carcinoma are among the topics of six newly funded feline-focused studies.
Feline diabetes pill gets FDA green lightDecember 9, 2022Bexacat has been approval by the U.S. Food and Drug Administration (FDA) for improved glycemic control in diabetic cats. Developed by Elanco Animal Health, the oral medication, which contains the active ingredient bexagliflozin, marks the first sodium-glucose cotransporter 2 (SGLT2) inhibitor (i.e. not insulin) approved by FDA in any animal species, the agency reports.
